YM's AeroLEF on hold

YM BioSciences (TSX:YM; AMEX:YMI) fell C$0.13 (11%) to C$1.08 on Thursday after FDA placed on hold the Phase II AP5 trial of AeroLEF to treat acute pain. The company said FDA requested additional safe...